Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 37 - Drugs for immunological or allergic disorders
Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2010
11/11/2010US20100285068 Method for the internalization of non-invasive bacteria in eukaryote cells
11/11/2010US20100285067 Interferon-beta production modulating listeria strains and methods for using same
11/11/2010US20100285064 Adjuvant composition for vaccine
11/11/2010US20100285057 Heat treated bacterins, and emulsion vaccines prepared from such heat treated bacterins
11/11/2010US20100285056 Baculovirus-Based Vaccines
11/11/2010US20100285055 Activation of natural killer (NK) cells and methods of use
11/11/2010US20100285052 Chemically Programmable Immunity
11/11/2010US20100285049 Ex vivo animal or challenge model as method to measure protective immunity directed against parasites and vaccines shown to be protective in the method
11/11/2010US20100285048 Use of flagellin in the immunotherapy of yersinia pestis
11/11/2010US20100285047 Therapeutics and diagnostics for group a streptococci
11/11/2010US20100285043 Mite antigenic rice
11/11/2010US20100285041 Class A Oligonucleotides with Immunostimulatory Potency
11/11/2010US20100285040 Methods of enhancing immune response using electroporation-assisted vaccination and boosting
11/11/2010US20100285036 Anti-CD100 Neutralizing Antibodies and Methods of Using the Same
11/11/2010US20100285035 High Affinity Antibody Antagonists of Interleukin-13 Receptor Alpha 1
11/11/2010US20100285034 Method
11/11/2010US20100285024 Vaccine compositions and methods for treatment of mucormycosis and other fungal diseases
11/11/2010US20100285020 Leukemic cell cns infiltration controlled by notch-induced chemotaxis
11/11/2010US20100285019 Anti-IL-17F Antibodies and Methods of Use Thereof
11/11/2010US20100285014 Immunoglobulin fusion proteins
11/11/2010US20100285003 Therapeutic peptides and uses thereof
11/11/2010US20100285002 Treatment or prevention of inflammation by targeting cyclin d1
11/11/2010US20100284989 15-pgdh in colon cancer
11/11/2010US20100284972 Compositions and methods for making alpha-(1,2)-branched alpha-(1,6) oligodextrans
11/11/2010US20100284970 Benzimidazole modulators of h1 receptor and/or ns4b protein
11/11/2010US20100284967 Modified phage for displaying post-translationally modified proteins and uses thereof
11/11/2010US20100284965 Compositions and methods for adoptive and active immunotherapy
11/11/2010US20100284963 Growth regulatable recombinant bcg immunogenic compositions
11/11/2010US20100284961 MCP-1 binding nucleic acids
11/11/2010US20100284958 BoNT/A Peptides and Methods of Predicting and Reducing Immunoresistance to Botulinum Toxin Therapy
11/11/2010DE102009018133A1 Pharmazeutische Zusammensetzung zur Behandlung von dermatologischen Autoimmunerkrankungen A pharmaceutical composition for the treatment of dermatological autoimmune diseases
11/11/2010CA2760890A1 Anti-cd100 antibodies and methods for using the same
11/11/2010CA2760764A1 Multi-valent adjuvant display
11/10/2010EP2248832A1 A g-csf conjugate modified by water-soluble polymer
11/10/2010EP2248831A1 Glycosylated antibodies
11/10/2010EP2248830A1 Use of antagonist anti-CD40 antibodies for treatment of autoimmune and inflammatory diseases and organ transplant rejection
11/10/2010EP2248811A1 2-oxochromene derivative
11/10/2010EP2248529A1 Modulation of NKG2D
11/10/2010EP2248522A1 Immunosuppressive macrolide powder for oral suspension
11/10/2010EP2247597A1 Fused heteroaryl modulators of glucocorticoid receptor, ap-1, and/or nf-kb activity and use thereof
11/10/2010EP2247584A1 Fused pyridines active as inhibitors of c-met
11/10/2010EP2247309A2 Tapasin augmentation for enhanced immune response
11/10/2010EP2247308A1 Adjuvant compositions comprising poly-ic and a cationic polymer
11/10/2010EP2247294A2 Macrolides for treating diseases mediated through pde inhibition
11/10/2010EP1556081B1 Recombinant intracellular pathogen immunogenic compositions and methods for use
11/10/2010CN1939412B Medicinal composition with dauricine and houttuynin sodium
11/10/2010CN1927387B Application of interleukins-15 in preparation of medicine for tumor immunization therapy and immunotherapy drug
11/10/2010CN1872071B Medication for enhancing body immunity, and fighting against senium, and preparation method
11/10/2010CN1816350B Mucosal vaccines with chitosan adjuvant and/or meningococcal antigens
11/10/2010CN1561208B Methods to mobilize progenitor/stem cells
11/10/2010CN101883856A Influenza virus-like particles (VLPs) comprising hemagglutinin produced within a plant
11/10/2010CN101883779A Crystalline peptide epoxy ketone protease inhibitors and the synthesis of amino acid keto-epoxides
11/10/2010CN101883765A Amorphous form of heterocyclic compound, solid dispersion and medicinal preparation each comprising the same, and process for production of the same
11/10/2010CN101883584A Allergen desensitization method
11/10/2010CN101880640A Klebsiella pneumoniae (Mannose-sensitive hemagglutination) pilus strain
11/10/2010CN101880324A Monoclonal antibody of anti-human SIRPalpha, cell strain, preparation method and application thereof
11/10/2010CN101880283A Azaindole kinase inhibitors
11/10/2010CN101880277A Aza spiro alkane derivatives as inhibitors of metallproteases
11/10/2010CN101880246A Substituted benzoyl urea compound and preparation method and application thereof
11/10/2010CN101880217A Medicinal composition for treating immunological diseases, preparation and application thereof
11/10/2010CN101879276A Health wine for invigorating kidney and strengthening yang
11/10/2010CN101879246A Traditional Chinese medicine for treating lupus erythematosus
11/10/2010CN101879242A Traditional Chinese medicine composition for treating chronic virus b hepatitis through immunity regulation and control
11/10/2010CN101879208A Method for extracting total flavonoids from mung bean shell
11/10/2010CN101879191A Medicinal composition
11/10/2010CN101879182A Composite polysaccharide for resisting radiation
11/10/2010CN101879176A Compound ivermectin injection for treating mite infection of dog and preparation method thereof
11/10/2010CN101879175A Dashing agent of ivermectin and levamisole and preparation method thereof
11/10/2010CN101879165A Novel antihypertensive medicament compound preparation
11/10/2010CN101417131B External medicine combination for treating skin allergic disease
11/10/2010CN101406476B Agent for treating skin peeling and allergy
11/10/2010CN101380339B Extraction method of Heidouba effective constituent
11/10/2010CN101314026B Serositis in duckling vaccine oral liquid synergistic agent for poultry biology and preparation method thereof
11/10/2010CN101293070B Extraction of seal wort oligose with effect of reinforcing immune function from seal wort
11/10/2010CN101284026B Chinese medicinal composition for treating skin hypersensitivity disease
11/10/2010CN101269164B Method of preparing virus bacterium blood serum Chinese aloe vaccine powder preparation and oral liquid for livestock, poultry biology and aquatic animal
11/10/2010CN101265301B Panax japonicus polysaccharides, preparation method and use thereof
11/10/2010CN101244049B Clenbuterol hydrochloride double-layer sustained release tablets and preparation thereof
11/10/2010CN101104006B Method for preparing Chinese caterpillar fungus extracting concentrated liquid and application thereof
11/10/2010CN101091789B Application of ocean collagen peptide in preparing medicine or foodstuff for adjusting immunity
11/09/2010US7829693 Compositions and methods for inhibiting expression of a target gene
11/09/2010US7829683 Polynucleotides encoding modified HIV-1 gp41 membrane polypeptides
11/09/2010US7829675 TWEAK receptor
11/09/2010US7829573 Therapeutic combinations of antihypertensive and antiangiogenics agents
11/09/2010US7829570 Substituted 4-amino isoxazolo[5,4-d]pyrimidines as kinase inhibitors
11/09/2010US7829561 interleukin-1B converting enzyme inhibitors such as 3-(6,11-Dioxo-1,2,3,4-tetrahydro-pyridazino[1,2-b]phthalazin-1-carboxamido)-5-fluoro-4-oxo-pentanoic acid, that mediate cell apoptosis and inflammation, used for cell or organ preservation and the treatment of osteoarthritis and rheumatoid arthritis
11/09/2010US7829534 Methods for protecting allogeneic islet transplant using soluble CTLA4 mutant molecules
11/09/2010US7829533 Cyclosporin analog formulations
11/09/2010US7829092 Recombinant anti-VLA4 antibody molecules
11/09/2010US7829090 Human antibody molecules for IL-13
11/09/2010US7829064 antigen binding molecules conjugated to lipids, polymer carriers, micelles, nanoparticles or mixtures and effectors, used for therapy of diagnosis
11/09/2010US7827986 Methods for treating jaw pain
11/09/2010CA2488279C Anti-inflammatory compositions derived from chicory
11/09/2010CA2484188C Tachykinin receptor antagonists
11/09/2010CA2412493C Purging of cells using viruses
11/09/2010CA2407659C Growth hormone secretagogues
11/09/2010CA2380070C New derivatives of hydantoines, thiohydantoine, pyrimidinediones and thioxopyrimidinones, their preparation methods and their application as medications
11/09/2010CA2223532C Monkey monoclonal antibodies specific to human b7.1 and/or b7.2 primatized forms, pharmaceutical compositions
11/04/2010WO2010127301A1 Method of treating allergic conjunctivitis with cyclosporin compositions
11/04/2010WO2010126967A1 Ex-vivo treatment of immunological disorders with pkc-theta inhibitors
1 ... 244 245 246 247 248 249 250 251 252 253 254 255 256 257 258 259 260 261 262 263 264 ... 1172